GGrantIndex
Sort

82,697 grants matching vaccine development

Chemically Programmed Immunity

$911,805
Carlos F Barbas · Scripps Research Institute, The · DP1 · FY2013 · CA

Host Immune Responses to Antigens of Malaria Parasites

$911,725
Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants

$911,707
Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2022 · DE

Immune Analytics Core (IAC)

$911,671
Kristina Abel · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI

Defining Drivers of HPV-associated Carcinogenesis

$911,640
Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2021 · CA

Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy

$911,539
Jennifer R Grandis · University Of California, San Francisco · R35 · FY2024 · CA

PREVENT EFFICACY POOL: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM

$911,531
Chinthalapally Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2021 · CA

Cytokine Gene Therapy of Cancer - Preclinical Studies

$911,332
University Of Pittsburgh At Pittsburgh · P01 · FY2005 · CA

iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium

$911,328
Powel H Brown · University Of Tx Md Anderson Can Ctr · UG1 · FY2022 · CA

Project 3 - USUHS

$911,234
Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2021 · AI

Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV

$911,231
William R Schief · Scripps Research Institute, The · R01 · FY2020 · AI

Lysis-free extraction of biopharmaceuticals from the periplasm of Clean Genome E. coli

$911,189
Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2019 · AI

CRYPTOCOCCUS NEOFORMANS--A MODEL FOR PATHOGENIC FUNGI

$911,161
Duke University · P01 · FY2003 · AI

Targeting PD-1 Pathway for Functional Cure of AIDS

$911,104
Rama Rao Amara · Emory University · R37 · FY2019 · AI

Structure-based design of coronavirus subunit vaccines

$911,083
Lanying Du · New York Blood Center · R01 · FY2018 · AI

Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children

$911,002
Bryan David Bryson · Massachusetts General Hospital · R01 · FY2024 · AI

Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice

$910,966
Daniel Kulp · Wistar Institute · R01 · FY2024 · AI

A protease-deficient, low mutation rate E. coli for biotherapeutics production

$910,959
Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2013 · GM

Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity

$910,923
Lallan Giri · Biologics Resources, Llc · R01 · FY2017 · AI

Advancing HIV Vaccine Development with a Lipid Nanodisc Platform

$910,905
Kimmo Ilmari Rantalainen · Scripps Research Institute, The · R56 · FY2025 · AI

O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis

$910,903
Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2025 · AI

Identification of the Initial Targets of Transmission

$910,732
Thomas Hope · Northwestern University At Chicago · R37 · FY2022 · AI

Mali International Center for Excellence in Research: Malaria immunology

$910,590
Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Structure-Based Design of Drugs and Vaccines for Target*

$910,534
Rutgers The St Univ Of Nj New Brunswick · P01 · FY2003 · GM

RAPID VACCINATION OF HARD TO REACH POPULATI0NS

$910,460
New York Academy Of Medicine · R01 · FY2005 · DA